SUSINI, TOMMASO
 Distribuzione geografica
Continente #
NA - Nord America 3.435
EU - Europa 2.041
AS - Asia 348
AF - Africa 11
OC - Oceania 2
SA - Sud America 2
Totale 5.839
Nazione #
US - Stati Uniti d'America 3.425
PL - Polonia 537
IT - Italia 380
SE - Svezia 325
IE - Irlanda 286
UA - Ucraina 188
HK - Hong Kong 182
DE - Germania 111
CN - Cina 71
FI - Finlandia 64
GB - Regno Unito 61
JO - Giordania 31
RU - Federazione Russa 28
TR - Turchia 21
IN - India 19
CH - Svizzera 17
FR - Francia 16
VN - Vietnam 14
SC - Seychelles 11
CA - Canada 10
BE - Belgio 8
AT - Austria 7
ES - Italia 6
SG - Singapore 6
NL - Olanda 4
IR - Iran 2
AR - Argentina 1
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
CY - Cipro 1
KR - Corea 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 5.839
Città #
Warsaw 536
Fairfield 518
Chandler 372
Jacksonville 287
Dublin 286
Ashburn 278
Woodbridge 237
Seattle 206
Cambridge 190
Wilmington 180
Houston 174
Hong Kong 118
Ann Arbor 108
Princeton 78
Altamura 63
Lawrence 62
Boston 50
Boardman 48
Beijing 46
Buffalo 46
Florence 43
Medford 37
San Diego 30
Kent 19
New York 19
West Jordan 19
Izmir 18
Shanghai 18
Milan 16
Moscow 16
Bern 15
Norwalk 15
Dong Ket 12
Frankfurt Am Main 11
Auburn Hills 10
Falls Church 10
Hillsboro 10
Rome 10
Toronto 9
Bologna 8
Brussels 8
Charlotte 8
Andover 7
Salerno 7
Barcelona 6
Saint Petersburg 6
Verona 6
Dearborn 5
Siena 5
Biella 4
Chennai 4
Phoenix 4
Portoferraio 4
Pratovecchio 4
Scandicci 4
Singapore 4
Viareggio 4
Vienna 4
Bremen 3
Erba 3
Laurel 3
Los Angeles 3
New Delhi 3
Piombino 3
Pune 3
Siracusa 3
Stagno 3
Arzano 2
Calcinaia 2
Campobasso 2
Cascina 2
Cormano 2
Foshan 2
Genoa 2
Isfahan 2
Leawood 2
London 2
Lucca 2
Monzuno 2
Nanjing 2
Newark 2
Paris 2
Prato 2
Redwood City 2
Reggio Calabria 2
Serravalle Scrivia 2
Tappahannock 2
Uzzano 2
Vicchio 2
Vicenza 2
Anghiari 1
Bari 1
Botosani 1
Cagliari 1
Capannori 1
Capua 1
Cedar Knolls 1
Cernobbio 1
Chesterfield 1
Chicago 1
Totale 4.405
Nome #
COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? 230
Raccomandazioni cliniche per il carcinoma mammario 221
Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer. 203
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. 176
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 126
Expression of FGD3 gene as prognostic factor in young breast cancer patients 125
Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma 124
TRPA1 mediates aromatase inhibitor-evoked pain by the aromatase substrate androstenedione 114
Relationship between cervical dilation and time to delivery in women with preterm labor 109
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy. 106
Evolution of Adjuvant Chemotherapy for Breast Cancer: Review of Our Experience with Three Chemotherapy Regimens and Trastuzumab, Between 2000 and 2017 105
EXPRESSION OF THE RETINOBLASTOMA-RELATED GENE RB2/P130 CORRELATES WITH CLINICAL OUTCOME IN ENDOMETRIAL CANCER 103
EPITHELIAL OVARIAN TUMORS IN THE REPRODUCTIVE AGE GROUP: AGE IS NOT AN INDEPENDENT PROGNOSTIC FACTOR 103
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. 101
GIANT PELVIC RETROPERITONEAL LIPOSARCOMA 101
COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? 95
Day Surgery Management of Early Breast Cancer: Feasibility and Psychological Outcomes 94
Expression of Endothelin-1 gene and protein in human granulosa cells. 91
Platelet-activating factor in human endometrium. 91
Masson's Vegetant Hemangioendothelioma Arising in the Uterine Cervix During Pregnancy: A Case Report 90
Expression of metalloproteinases 2 and 9 and cyclooxygenase 2 in endometrial carcinoma. 86
Preoperative assessment of HER-2/neu status in breast carcinoma: The role of quantitative real-time PCR on core-biopsy specimens 86
Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment? 84
Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: Comparison with other clinical-pathologic parameters. 82
Schauta-Amreich vaginal hysterectomy and Wertheim-Meigs abdominal hysterectomy in the treatment of cervical cancer: A retrospective analysis. 82
Gastric motor responses elicited by vagal stimulation and purine compounds in the atropine-treated rabbit. 81
GnRH analogs in gynecological oncology: a review. 81
Prediction of preterm delivery by fetal fibronectin in symptomatic and asymptomatic women with cervical length ≤20 mm 81
Radiofrequency Ablation for Minimally Invasive Treatment of Breast Carcinoma. A Pilot Study in Elderly Inoperable Patients. 80
Identification, characterization, and biological activity of endothelin receptors in human ovary. 79
Sex steroid modulation of AT2 receptors in human myometrium. 78
Reproductive performance before and after abdominal myomectomy: a retrospective analysis. 78
Preoperative evaluation of tumor ploidy in endometrial cancer: an accurate tool to identify patients at risk for extrauterine disease and recurrence. 77
Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly 77
Gynecologic oncologic surgery in the elderly: A retrospective analysis of 213 patients. 76
Vaginal hysterectomy versus abdominal hysterectomy for the treatment of stage I endometrial adenocarcinoma. 75
Management of benign adnexal masses by vaginal route 74
Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1 74
Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients. 74
Three Classes of radical vaginal hysterectomy for treatment of endometrial and cervical cancer. 71
Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients. 69
Changing trends in mastectomy and breast reconstruction. Analysis of a single-institution experience between 2004-2016 69
ANALISI DELLA CORRELAZIONE TRA TLI E PARAMETRI ISTOPATOLOGICI NEL CARCINOMA DELLA CERVICE UTERINA 67
RADIOFREQUENCY BIPOLAR COAGULATION FOR RADICAL HYSTERECTOMY: TECHNIQUE, FEASIBILITY AND COMPLICATIONS 66
Axillary ultrasound scanning in the follow-up of breast cancer patients undergoing sentinel node biopsy. 66
Platelet-activating factor in human endometrium 64
Sociodemographic and clinical features of gender identity disorder: an Italian multicentric evaluation. 63
Indice di marcatura nei tumori della cervice uterina: relazioni con parametri clinici ed istopatologici. 63
Axillary ultrasound scanning in the follow up of breast cancer patients submitted to sentinel node biopsy. 61
Ovarian Cancer Initially Presenting as Intramammary Metastases and Mimicking a Primary Breast Carcinoma: A Case Report and Literature Review 61
Role of axillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy 59
Long Term Results after Neoadjuvant Chemotherapy for Breast Cancer: A Single-center Experience 59
Hormonal and local regulation of uterine activity during parturition: Part II - The Prostaglandin and Adrenergic systems. 59
Preoperative evaluation of tumor ploidy in endometrial carcinoma - An accurate tool to identify patients at risk for extrauterine disease and recurrence 56
Extraperitoneal pelvic lymphadenectomy: A new simple and quick technique to complement vaginal operations for cervical and endometrial cancer. 55
PREGNANCY-ASSOCIATED ECTOPIC DECIDUA 54
Cell kinetics parameters in uterine cervix carcinoma. 54
Proliferative activity in carcinoma of the uterine cervix. 50
Vaginal radical hysterectomy versus abdomianal radical hysterectomy in the treatment of early-stage cervical cancer. (Letter) 47
TLI and clinical-histopathological parameters in uterine cervix carcinoma. 46
Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: DNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. 45
Medicines for headache before and during pregnancy: a retrospective cohort study (ATENA study) 44
Ureteral obstruction due to retroperitoneal endometriosis: A conservative approach including surgery and Gn-RH analog use. 43
Wertheim-Meigs or Schauta-Amreich hysterectomy. (Letter) 43
DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study 43
Hypothesis of clinical use of preoperative evaluation of DNA-index in endometrial carcinoma management. 40
Radial scar without associated atypical epithelial proliferation on image-guided14-gauge needle core biopsy: Analysis of 49 cases from a single-centre and reviewof the literature 40
FGD3 Gene as a New Prognostic Factor in Breast Cancer 37
Immunohistochemical evaluation of fgd3 expression: A new strong prognostic factor in invasive breast cancer 33
Predicting the status of axillary lymph nodes inbreast cancer: a multiparameter approach including axillary ultrasound scanning. 32
Nuovi Fattori Prognostici in Ginecologia Oncologica 29
Increased expression of metalloproteinase-2 in endometrial carcinoma. 28
Role of preoperative breast MRI in ductal carcinoma in situ for prediction of the presence and assessment of the extent of occult invasive component. 28
Immediate-implant-based-breast-reconstruction with two-stage expander-implant reconstruction versus one-stage-reconstruction with acellular dermal matrix: Analysis of patients’ satisfaction 25
Establishment and characterization of a new spontaneously immortalized ER-/PR-/HER2+ human breast cancer cell line, DHSF-BR16 23
Immunohistochemical evaluation ofCOL11A1 and FGD3 expression in invasive brast cancer 23
RELATIONSHIP BETWEEN CERVICAL DILATATION AND TIME FROM ADMISSION TO DELIVERY IN WOMEN WITH PRETERM LABOR 19
Prognostic Role of Tumor Size Reduction >50% after Neoadjuvant Chemotherapy for Breast Cancer 16
Prognostic role of tumor size reduction >50% after neoadjuvant chemotherapy for breast cancer 13
Breast lesions of uncertain malignant potential (B3) and the risk of breast cancer development: A long-term follow-up study 12
Immunohistochemical evaluation of COL11A1 and FGD£ expression in invasive breast cancer 9
Intertwining art, religion and anatomy: did Michelangelo Buonarroti influence Berengario da Carpi’s representation of a maternal death? 9
Nuclear expression of β-catenin is associated with improved outcomes in endometrial cancer 9
Promote community engagement in participatory research for improving breast cancer prevention: The P.I.N.K. study framework 6
Breast cancer in pregnancy: concurrent cesarean section, nipple-sparing mastectomy, and immediate breast reconstruction-case report 3
Prognostic factors research in breast cancer patients: New paths 3
Breast cancer risk and prevention: A step forward 3
Reducing the Use of Frozen Section for Sentinel Node Biopsy in Breast Carcinoma: Feasibility and Outcome 1
Totale 5.931
Categoria #
all - tutte 16.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019368 0 0 0 0 0 0 0 0 0 0 203 165
2019/20201.304 109 97 32 129 130 169 133 165 119 73 124 24
2020/2021918 87 60 79 91 42 123 31 82 68 134 43 78
2021/2022548 29 60 27 19 22 21 39 35 26 21 117 132
2022/20231.423 147 213 73 131 103 266 171 70 157 22 43 27
2023/2024568 27 57 107 45 29 59 14 152 15 31 32 0
Totale 5.931